Chemotherapy for Pancreatic Cancer

Chemotherapy for Pancreatic Cancer: What Patients Should Know Chemotherapy is used at most stages of pancreatic cancer. It can prepare a tumor for surgery, lower the risk of the cancer coming back, or control cancer that has spread. The right plan depends on the stage, the patient’s general health and how the cancer responds. This guide to pancreatic cancer chemotherapy covers treatment by stage, its place around surgery, how drugs are chosen, side effects, monitoring and options if the cancer returns. Chemotherapy for Pancreatic Cancer by Stage Chemotherapy has a different goal at each stage, from preparing for surgery to controlling cancer that has spread. Stage What it means Role of chemotherapy Resectable The tumor can be removed by surgery. Usually given after surgery, and sometimes before it too. Borderline resectable The tumor involves a major blood vessel or nearby tissue, which can make removal harder. Often given first, to try to make surgery possible. Locally advanced The tumor has grown into nearby blood vessels and usually cannot be removed. Usually given first. Some patients may be able to have surgery afterward. Metastatic The cancer has spread to other organs. Main treatment, to slow the cancer and control symptoms. Palliative care, which eases symptoms and supports comfort, can be offered alongside cancer treatment at any stage. Chemotherapy Before and After Pancreatic Cancer Surgery When a tumor can be removed, surgery usually comes first. Chemotherapy after recovery is called adjuvant treatment. It aims to lower the chance that the cancer returns. For borderline resectable tumors, chemotherapy usually comes first. This is called neoadjuvant treatment. Scans are repeated afterward to check whether surgery has become possible. A team of surgeons, oncologists and other specialists reviews the results together. Some patients go on to surgery. Others continue chemotherapy. What Affects the Choice of Pancreatic Cancer Chemotherapy Several factors shape the choice of chemotherapy. Doctors weigh: • The stage and the goal of treatment.

• Daily activity level and general health. • Earlier treatment and how the cancer responded. Fitter patients are often offered a combination of drugs, such as FOLFIRINOX (four drugs) or gemcitabine with nab-paclitaxel. Gemcitabine alone is less intensive. It may suit patients who are less fit. After surgery, a combination is used if the patient can cope with it. Otherwise, gemcitabine-based treatment is often used. Side Effects of Pancreatic Cancer Chemotherapy Side effects depend on the drugs and the patient. Care teams can prevent or ease many of them. Common effects, for example with FOLFIRINOX, include: • Fatigue. • Nausea and loss of appetite. • Diarrhea. • Low blood counts, which raise the risk of infection. • Numbness or tingling in the hands and feet, which can be worse in the cold. • Hair thinning. Before chemotherapy that includes fluorouracil, European regulators recommend a test for DPD deficiency, a gene-related enzyme problem that raises the risk of severe side effects. Call your treatment team straight away if you have a high temperature or other signs of infection, or severe diarrhea or vomiting that stops you drinking. Use the emergency number your team gives you. Report new symptoms early. Supportive medicines can help, and treatment can be adjusted if side effects become hard to manage. For a detailed look at drug regimens, side effects, and what to expect, read a comprehensive guide on Chemotherapy for Pancreatic cancer. Monitoring Pancreatic Cancer During Chemotherapy During treatment, doctors judge whether chemotherapy is working by combining several checks, not one result: • Scans show whether the tumor is stable, shrinking or growing. • The blood marker CA 19-9 is only one clue. A rising level can point to progression. A normal level does not rule out recurrence. • Symptoms and daily activity show how the patient is coping. In advanced disease, a stable scan is often a good sign. Slowing the cancer is a goal of treatment.

The plan is reviewed at regular checks and can change over time. Chemotherapy After Recurrence or Progression If these checks show the cancer is growing, or if it returns after treatment, the plan is reviewed. Recurrence means the cancer has come back after treatment that removed all detectable disease. Progression means it has grown during treatment. The team looks at where the cancer is, what treatment was used before, how it responded and how the patient is now. Patients whose cancer progressed on gemcitabine-based treatment may be offered a different combination. Some patients may be candidates for clinical trials. Getting a Second Opinion Chemotherapy can sometimes make surgery possible. The German guideline advises that patients whose tumor is first judged unable to be removed be referred to a center with high case numbers for a second opinion. A second opinion can review the stage, the scans and the treatment options. Bring scans, pathology reports and treatment history to that consultation.